Key result
Novel modular one-pot synthesis enables efficient production of the anticoagulant Idraparinux.
Answers are grounded in this paper and cite their sources.
Idraparinux is a fully O-sulfated α-methyl glycoside of heparin pentasaccharide motif known to interact with the antithrombin III domain and act as anticoagulant. The current most effective synthesis of Idraparinux is complicated and nonstereoselective, requiring numerous stepwise procedures with low yields. We report here an efficient modular one-pot synthesis of Idraparinux involving the use of a glycosyl phosphate with 6- O- tert-butyl diphenyl silyl group and a d-glucuronic acid-containing disaccharide thioglycoside with 6- O-acetyl group as donor building blocks for the α-directing one-pot glycosylations with an l-iduronic acid-containing disaccharide acceptor building block. The uronic acid was incorporated in a disaccharide module used in the one-pot synthesis to avoid the complicated late-stage installation of these acidic sugars. The one-pot synthesis of Idraparinux demonstrated here is an effective strategy and should be applicable to the modular assembly of other heparan sulfates with regiodefined sulfation pattern for functional study.
No takes yet. Share an insight, caveat, or question.
Dey et al. (2019) studied this question. Modular one-pot synthesis was evaluated. An efficient modular one-pot synthesis of the anticoagulant Idraparinux was developed using specific donor and acceptor building blocks.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: